Lv4
580 积分 2021-09-28 加入
A Phase II Study of Single Agent Bortezomib in Patients with Metastatic Breast Cancer: A Single Institution Experience
1年前
已完结
Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia
1年前
已完结
An integrated computational strategy to predict personalized cancer drug combinations by reversing drug resistance signatures
1年前
已完结
Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia
1年前
已完结
Imatinib mesylate inhibits proliferation and modulates cytokine expression of human cancer-associated stromal fibroblasts from colorectal metastases
1年前
已完结
Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies
1年前
已完结
RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
1年前
已完结
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
1年前
已完结
CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma
1年前
已完结
Basal-like molecular subtype and HER4 up-regulation and response to neoadjuvant chemotherapy in breast cancer
1年前
已完结
皖公网安备34019202002308
